FDA Investigator Yuanyuan Li
Yuanyuan Li has inspections in 3 countries as of 09 Apr 2024. Yuanyuan Li has collaborated with a combined 1072 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
30
Last Inspection Date:
09 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada,
Bulgaria
Co-Investigator(s):
Alan M Barker,
Alan M Roberts,
Ansalan E Stewart,
Ashley L Reiber,
Barbara D Wright,
Bonnie E Conley,
Bonnie E Pierson,
Bradley J Maunder,
Bruce H Mccullough,
Chery Grandinetti,
Christina A Miller,
Colleen E Burke,
Debra I Love,
Debra L Boyd Seale,
Denise L Burosh,
Donna D Gallien, MPH,
Dr. Zhou Chen (nmi), MD PhD,
Dustin R Abaonza,
Eric M Mueller, PharmD,
Gene D Arcy,
Jeanne J Thai,
Jennifer A D'angelo,
Jennifer C Adams,
Jennifer C Johnson,
Jesse A Vazquez,
Joseph A Piechocki,
Kimberly A Dutzek,
Lacey J Chessor,
Lacey J Rice,
Lauren N Howard,
Leeterry Moore,
Lequita M Mayhew,
Lisa Hayka,
Lisa Hornback,
M Anthonyabel I,
Marcia A Worley,
Margaret Torres Vazquez,
Matthew R Buenconsejo,
Michele Perry Williams,
Muhammad Naiman,
Nicholas P Diorio,
Nicholas Z Lu,
Nicole S Williams,
Pankaj H Amin,
Peng Zhou,
Prajakta A Varadkar,
Rachel E Mcguigan,
Rafael Padilla,
Robert J Ham,
Russell K Riley,
Shalonda C Clifford,
Stefen D Mcmillan,
Susan D Yuscius,
Susan Yuscius,
Tamara Brey,
Tenzin Jangchup,
Thomas W Nojek,
Veronica Bush,
Veronica L Bush,
Yiyue Zhang (nmi), PhD
Yuanyuan Li's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2022 | FDA 483 | David M. Lubeck MD - Form 483, 2022-04-20 |
May, 2022 | FDA 483 | Kenneth J Maverick, M.D. - Form 483, 2022-05-20 |
May, 2023 | FDA 483 | Mt. Sinai Hospital Medical Center IRB - Form 483, 2023-05-26 |
October, 2021 | FDA 483 | Adarsh Daswani, M.D. - Form 483, 2021-10-29 |
June, 2022 | EIR | AltaThera Pharmaceuticals LLC - EIR, 2022-06-17 |
June, 2022 | FDA 483 | AltaThera Pharmaceuticals LLC - Form 483, 2022-06-17 |
December, 2021 | EIR | AbbVie Inc. - EIR, 2021-12-15 |
April, 2021 | FDA 483 | Ning Z. Wu, M.D. - Form 483, 2021-04-13 |
May, 2021 | FDA 483 | CellTrans Inc. - Form 483, 2021-05-06 |
January, 2022 | FDA 483 | Manish Jain, M.D. - Form 483, 2022-01-24 |
June, 2021 | FDA 483 | Sunandana Chandra, M.D. - Form 483, 2021-06-16 |
December, 2023 | FDA 483 | IIT Research Institute - Form 483, 2023-12-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more